Tag: Weight Loss Surgery and Bariatric

Black patients equally likely to discuss, less likely to progress to metabolic and bariatric surgery than non-Black patients

Authors say clinicians should evaluate trade-offs between pharmaceutical and surgical management of obesity

Reduced risk was more pronounced in those with type 2 diabetes, but was also seen in those without T2D

Metabolic surgery linked to lower risk for progression of kidney impairment compared with GLP-1RA

Benefits include remission and control of hypertension while cutting dependence on antihypertensive medications

Significantly lower risk of major adverse cardiovascular events, all-cause mortality seen in metabolic surgery group

Findings seen in high-risk patients with body mass index ≥70 preparing to undergo metabolic surgery

Findings seen at five, 10, and 15 years following surgery versus nonsurgical, matched controls

Surgical treatment benefit greatest in women with baseline insulin levels above the median

SG was followed by active listing in 37 of 54 patients; 20 patients received KT during 20.9 months after SG